PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 10, 2026Frontiers in Medicine0 citationsOpen Access

Case Report: A case of drug-induced pancreatitis caused by paroxetine with a literature review

YWYangpeng WuDLDongFeng LvLLLihua Liu

Key Result

Paroxetine may induce acute pancreatitis in a 28-year-old woman even at standard doses, with symptoms resolving after drug cessation.

Key Points

  • The aim is to highlight the link between paroxetine and drug-induced pancreatitis through a detailed case report.
  • Case presentation of a 28-year-old woman with severe depression
  • Self-initiated paroxetine 20 mg daily
  • Monitoring of symptoms, laboratory tests, and CT imaging
  • Immediate cessation of paroxetine upon diagnosis of pancreatitis
  • Follow-up with supportive care and discharge on trazodone.
  • Patient developed acute pancreatitis after 24 hours of taking paroxetine
  • Elevated pancreatic enzymes and CRP levels confirmed diagnosis
  • CT scan revealed mild pancreatitis; no traditional risk factors were identified
  • Recovery within 72 hours after discontinuation of paroxetine.
  • Patient discharged recurrence-free on trazodone.

Structured PICO

Does paroxetine induce acute pancreatitis in patients lacking traditional risk factors?

P
Population
28-year-old Chinese woman with severe depression, lacking traditional risk factors for acute pancreatitis (n=1)
I
Intervention
Paroxetine 20 mg oral once daily
O
Outcome
Acute pancreatitissafety

Paroxetine may induce acute pancreatitis even at standard doses, highlighting the need to consider drug-induced pancreatitis in patients lacking traditional risk factors.

Limitations

  • Comprehensive etiological screening (MRCP, serum IgG4 subclass, viral serologies) was not performed
  • Positive rechallenge was patient-initiated and not physician-supervised
  • Genetic susceptibility factors and pharmacogenomic markers were not assessed
  • Single case from one center

Abstract

Background Acute pancreatitis (AP) incidence is ~76.2 per 100,000. Drug-induced pancreatitis (DIP) accounts for 2%, yet 500 drugs are implicated. Evidence linking the SSRI paroxetine to AP remains sparse. Case presentation A 28-year-old woman with severe depression self-initiated paroxetine 20 mg once daily; within 24 h she developed persistent epigastric pain and bloating. After brief relief with intravenous fluids she re-administered the same dose, and symptoms recurred within 24 h. Labs showed elevated pancreatic enzymes and CRP. CT revealed mild pancreatitis. No alcohol, hyperlipidemia or other classic risk factors were identified. Paroxetine was immediately discontinued; supportive care led to symptom and enzyme normalization within 72 h. She was discharged on trazodone and remains recurrence-free. Discussion Population studies have not established a significant SSRI–AP association, probably because of the extreme rarity of such events (0.01%). The positive rechallenge observed here provides robust individual-level evidence of causality, supported by formal probability scales and international criteria. SSRIs may precipitate AP through serotonin-mediated β -cell dysfunction, oxidative stress, or idiosyncratic hypersensitivity. Early recognition is critical because DIP is usually reversible after drug withdrawal. Conclusion This case suggests that paroxetine may induce AP even at standard doses. Clinicians should consider DIP in patients lacking traditional risk factors, especially after self-rechallenge. Early recognition, immediate drug cessation and supportive therapy ensure excellent recovery.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Wu et al. (2026) studied this question. Paroxetine may induce acute pancreatitis in a 28-year-old woman even at standard doses, with symptoms resolving after drug cessation.

synapsesocial.com/papers/696321d491e05aa366cb81b1https://doi.org/10.3389/fmed.2025.1688065
Ask AI
Helpful
Bookmark
Share
View Full Paper